Morbidity and hospitalization data as a result of the corona virus are rampant in South Africa after the outbreak of the omicron variant in the country, due to the attempt by the authorities in Pretoria to calm the winds and broadcast a routine.
Data released today show that the rate of hospitalization due to illness in Corona in Gauteng province, which also includes the city of Johannesburg, the largest city in the country, has risen by 330 percent over the past two weeks.
This is a district with the lowest immunization rate in the country with less than 40 percent of the district's population being vaccinated.
Data suggest an association between the omicron and the dramatic increase in morbidity after a sample test of the genetic sequencing of the virus among inpatients showed that almost all were infected with the omicron strain.
The case also raises the concern that the initial indications that the new variant does not cause severe morbidity were incorrect.
Vaccination of a woman in Swatu, near Johannesburg, South Africa, Photo: AP
As morbidity and hospitalization rise in South Africa, the variant continues to spread around the world.
Japan this morning approved the first case of the corona variant in its territory.
The variant in the variant is a tourist in his 30th year of life who came to the country from Namibia.
The secretary of the Japanese cabinet, Hirkozu Matsusun, announced that the man had already been diagnosed at the airport and taken away.
The senior did not reveal the identity of the infected person but said that everyone who came in contact with him was examined.
Japan closed its borders to foreigners almost completely on Thursday at least a month, in order to try to delay the arrival of the Omicron to the country's borders.
Meanwhile, Modern CEO Stephen Bensel said tonight in an interview published in the British newspaper "Financial Times" that existing vaccines are far less effective in dealing with the Omicron strain than previous strains of Corona virus. Bensel warned that it would be months before drug companies could produce the vaccine Against the new strain.
Modern CEO Stefan Bensel, Photo: Brenda Bensel
Stephen Bensell said the high number of mutations in the spike protein, which the virus uses to infect human cells, and the rapid spread of the strain in South Africa, suggest that current vaccine production may need to be changed next year.
Bensel said he does not see a situation where the vaccine faces the same level as against the Delta strain.
He added: "I think it will be a significant drop. I just do not know how much because we have to wait for the data. But all the scientists I spoke to said 'it's not going to be good'."
Following the CEO of the European pharmaceutical company's market, they reacted with sharp declines. The Euro 50 stock index plunged 1.7% as investors tried to avoid companies in risk areas such as aviation and tourism. .5% and in 1.2%.
Shares of companies in areas affected by the epidemic such as aviation, hotels and banking have been experiencing a significant decline over the past week due to the uncertainty caused by the spread of the Omicron variant.
Last Friday, more than two trillion dollars worth of shares in the global market were written off following the outbreak of the new variant.
Were we wrong?
Fixed!
If you found an error in the article, we'll be happy for you to share it with us
